OTC Drug Market in India 2011 - Value Chain and Regulation, Competition, Strategic Recommendations

8/13/2019 OTC Drug Market in India 2011 - Value Chain and Regulation, Competition, Strategic Recommendations

1/27

Insert Cover Image using Slide Master ViewDo not distort

OC D M I (P III)O 2011 ISIEmergingMarketsPDF in isb from 202.174.120.2 on 2013 11 17 10:47:55 EST. DownloadPDF.

Downloaded by in-isb from 202.174.120.2 at 2013-11-17 10:47:55 EST. ISI Emerging Markets. Unauthorized Distribution Prohibited.


2/27

2OC DRG MARKE IN INDIA 2011.PP

D:

R OC

I

OC

I

B

C

L

C:

L P

C

I

A

B C

E OC

E

I O (OC) OC I INR 87.78 2009

CAGR 12.6% 2009 2015

H

M G, P & G, R

B M R, C, D. R, A H

ISIEmergingMarketsPDF in isb from 202.174.120.2 on 2013 11 17 10:47:55 EST. DownloadPDF.Downloaded by in-isb from 202.174.120.2 at 2013-11-17 10:47:55 EST. ISI Emerging Markets. Unauthorized Distribution Prohibited.


3/27


I

M OD & C

G I

C



4/27


P

: I P D I

,

D

,

D

D

P

,

,

D

,

,



5/27


D

: C. C

K

(IND) CDCO

H 2080

H 30 300

D

C

(P),

(PF)

(F)

K

H 3003000

A ,

(NDA)

A

CDCO

I

,

CDCO

I

P CDCO OC ,

D

K ,

FDA



6/276OC DRG MARKE IN INDIA 2011.PP

I,

: C D C O, M H F , G I

(), , ,

L , ,

R

R I

R

C D L M ( ADR)

L ,

L A

A

C D C

O

L

L

A

M ,

P

A




D I

N P P A (NPPA)

D P C

O, 1995

I

N D

P

A , 1985

A

D M

R A, 1954

I , , I

M D&C A

D&C A

D C

A, 1940

: I P A R G

,




I

M OD & C

G I

M C R




M (1/6)

E 13,420 , R I ,

125

I 2002, OC R G C

H , R, G P, P G, OC

P, 15 , , C

I 2010, R I

O A 2011, D,

: C ; F E F , F 2010; R D OC , A

2011; H P, R IC , C IQ

G, H

1961

G , API

A

.

P / L

R

89.6

76.074.167.8

0

50

100

0

20

40

60

R

INR

P

INR

2011201020092008

31




M (2/6)

E 14,900 , ,

,

I I, , E R F

OC B, B, C F, M3, N, N, R, , K,

, ,

H, A P

1984

F , API,

D. K.A.R

. ()

R

P / L74.7

70.269.4

49.4

0

20

40

60

80

0

20

40

60

R

INR

P

INR

2010200920082007

: C ; C IQ 31




M (3/6)

40 , 1200 80

I A 2010, M INR 1.3 ,

OC C L, P, P, L, R, D , M C, M

C, B, C, H, M, P, D

I M 2010, C , ,

P H INR 950

: C ; ND P C P P, M 2010; C IQ

M, M

1935

API, ,

D. .K.H

P / L

R

61.356.752.9

42.6

0

20

40

6080

0

10

20

3040

R

INR

P

INR

2011201020092008

31




M (4/6)

397 , A

,

I G, A A

I , , ,

, ,

OC A C , A I, A J A , A P

B, H B

CARE.

: C ; C IQ

C, N

1893

P

. P

31

1.10.90.9

0.7

0.0

0.5

1.0

1.5

0.0

0.2

0.4

0.60.8

P

INR

R

INR

2011201020092008

P / L

R




M (5/6)

P , 70

R L R P (LRP) P

R&D , K P I C. L, O, J

F A, M G, API

A

OC B, N P, F, C3

: C ; C IQ

M, M

1968

API

D B G

.

31

P / L

R

57.948.3

38.528.7

0

20

40

60

0

5

10

R

INR

P

INR

2011201020092008




M (6/6)

N D, D

1995

OC ,

R.C.J

OC

, ,

OC , N,

, N,G, ,

H 600 OC , C , R

B, L, H, K,

I H F, I, ,

G

1906

A

NA

: C



15/27


M (1/8)

GK 96,461 , 100

I I G P L

I ,

R&D

OC A, A, A, BC P, B, B, C, C, D, E,

N, N, , , ,

: C ; C IQ

B, K

1935

P , ,

C

A

P / L

R

2.02.02.11.7

0

1

2

3

0.0

0.5

1.0

1.52.0

2007

P

INR

R

INR

201020092008

31



16/27


M (2/8)

I 1996 CG

N 140 115,000

I , N I P L N 140

16% R&D 2010

OC C

R, N O OC INR 44 10

: C ; C IQ

B,

1996

P, ,

D

P / L

R

2.52.32.12.1

0

1

2

3

0.0

0.5

1.0

1.52.0

2010

P

INR

R

INR

200920082007

31



17/27


M (3/8)

I 46 , A, B, C ,I, J ,K , , 112,400

I P L.

I , M P E R L (PEARL)

M OC C , B , L C, REBRAND100 2010

A R, P IC L. OC

: C ; C IQ ; H P, R IC , J 2011

N ,

1849

API, B

D A.A

.

P / L

R

3.02.32.3

1.9

0

1

2

34

0

1

2

3

P

INR

R

INR

31

2010200920082007



18/27


M (4/8)

129,000 , ,

, , , ,

180

O I P G I

OC , , C D, A ,

: C ; C IQ

C, A

1837

C

R A. M

& .

31

P / L

R

3.73.7

3.43.0

0

1

2

3

4

0.0

0.5

1.0

1.5

2.0

R

INR

P

INR

2010200920082007



19/27


M (5/8)

27, 200,

,

O I R B I P. L.

OC D , A

C , ,

M , N G

I D 2010, P P L INR 32.6 OC

: C ; C IQ

B, K

1814

OC

R K

31

P / L

R

0.60.6

0.50.4

0.0

0.2

0.4

0.6

0.0

0.1

0.2

0.30.4

R

INR

P

INR

2010200920082007



20/27


M (6/8)

J&J 250 57 , 114,000

I I , J & J I

, ,

OC , , M, M, I, P, N, B, R, D,

N J,

1886

C ,

,

C.

&

P / L

R

2.82.72.93.0

0

1

2

34

0

1

2

3

P

INR

R

INR

2010200920082007

: C ; C IQ 31



21/27


M (7/8)

94,000, , ,

, , ,

I N 2009, M P

O I MD I

OC A, C , C, C, C, D. , D, L, M,

,

: C ; C IQ

N J,

1891

P M, ,

R . C

& . .

31

P / L

R

2.1

1.31.2

1.0

0

1

2

3

0.0

0.5

1.0

1.5

2007

R

INR

INR

201020092008



22/27


M (8/8)

F, A

2000

OC

R J. D

OC C, 2 ,

N R, 3

I A 2010,

I N

: C



23/27


R D

: P

P H L. C L.

C

, 00

D I L OC D

N ,

0, 00

C OC

A

, 00

FDA 500 ,

0, 0

D I M A P

OC 30P

0, 0

R P (FMCG) IC

OC

, 0

R L OC R G C H D , I

, 0

N P I OC

N

, 0

A P L M M

40 I

, 0



24/27


I

M OD & C

G I

M C R

C



25/27


R (1/2)

A II III

70% ,

C

L 300

P H

300

C

C

I

P P

A ,

OC , ,

OC I

. ,

: N A



26/27


R (2/2)

C OC

OC ,

M OC 12

C OC

OC

: N A

M OC I OC ,

& ,

;

OC

C



27/27

27

. & , & , , .

.

.

OC P M I N H I

.

F :

. , ,

() . . . () . . .

() . .

.

P: +91 33 4064 6215

EM: .@.

P: +91 22 4098 7530

EM: .@.

Documents

OTC Drug Market in India 2011 - Value Chain and Regulation, Competition, Strategic Recommendations